These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 19223389)
1. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Udler MS; Meyer KB; Pooley KA; Karlins E; Struewing JP; Zhang J; Doody DR; MacArthur S; Tyrer J; Pharoah PD; Luben R; Bernstein L; Kolonel LN; Henderson BE; Le Marchand L; Ursin G; Press MF; Brennan P; Sangrajrang S; Gaborieau V; Odefrey F; Shen CY; Wu PE; Wang HC; Kang D; Yoo KY; Noh DY; Ahn SH; Ponder BA; Haiman CA; Malone KE; Dunning AM; Ostrander EA; Easton DF; Hum Mol Genet; 2009 May; 18(9):1692-703. PubMed ID: 19223389 [TBL] [Abstract][Full Text] [Related]
2. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India. Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473 [TBL] [Abstract][Full Text] [Related]
3. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Meyer KB; O'Reilly M; Michailidou K; Carlebur S; Edwards SL; French JD; Prathalingham R; Dennis J; Bolla MK; Wang Q; de Santiago I; Hopper JL; Tsimiklis H; Apicella C; Southey MC; Schmidt MK; Broeks A; Van 't Veer LJ; Hogervorst FB; Muir K; Lophatananon A; Stewart-Brown S; Siriwanarangsan P; Fasching PA; Lux MP; Ekici AB; Beckmann MW; Peto J; Dos Santos Silva I; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Kerin MJ; Miller N; Marme F; Schneeweiss A; Sohn C; Burwinkel B; Guénel P; Truong T; Laurent-Puig P; Menegaux F; Bojesen SE; Nordestgaard BG; Nielsen SF; Flyger H; Milne RL; Zamora MP; Arias JI; Benitez J; Neuhausen S; Anton-Culver H; Ziogas A; Dur CC; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schmutzler RK; Engel C; Ditsch N; Brauch H; Brüning T; Ko YD; ; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Matsuo K; Ito H; Iwata H; Yatabe Y; Dörk T; Helbig S; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Chenevix-Trench G; ; ; Wu AH; Tseng CC; Van Den Berg D; Stram DO; Lambrechts D; Thienpont B; Christiaens MR; Smeets A; Chang-Claude J; Rudolph A; Seibold P; Flesch-Janys D; Radice P; Peterlongo P; Bonanni B; Bernard L; Couch FJ; Olson JE; Wang X; Purrington K; Giles GG; Severi G; Baglietto L; McLean C; Haiman CA; Henderson BE; Schumacher F; Le Marchand L; Simard J; Goldberg MS; Labrèche F; Dumont M; Teo SH; Yip CH; Phuah SY; Kristensen V; Grenaker Alnæs G; Børresen-Dale AL; Zheng W; Deming-Halverson S; Shrubsole M; Long J; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Kauppila S; Andrulis IL; Knight JA; Glendon G; Tchatchou S; Devilee P; Tollenaar RA; Seynaeve CM; García-Closas M; Figueroa J; Chanock SJ; Lissowska J; Czene K; Darabi H; Eriksson K; Hooning MJ; Martens JW; van den Ouweland AM; van Deurzen CH; Hall P; Li J; Liu J; Humphreys K; Shu XO; Lu W; Gao YT; Cai H; Cox A; Reed MW; Blot W; Signorello LB; Cai Q; Pharoah PD; Ghoussaini M; Harrington P; Tyrer J; Kang D; Choi JY; Park SK; Noh DY; Hartman M; Hui M; Lim WY; Buhari SA; Hamann U; Försti A; Rüdiger T; Ulmer HU; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Vachon C; Slager S; Fostira F; Pilarski R; Shen CY; Hsiung CN; Wu PE; Hou MF; Swerdlow A; Ashworth A; Orr N; Schoemaker MJ; Ponder BA; Dunning AM; Easton DF Am J Hum Genet; 2013 Dec; 93(6):1046-60. PubMed ID: 24290378 [TBL] [Abstract][Full Text] [Related]
4. Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium. Pasaniuc B; Zaitlen N; Lettre G; Chen GK; Tandon A; Kao WH; Ruczinski I; Fornage M; Siscovick DS; Zhu X; Larkin E; Lange LA; Cupples LA; Yang Q; Akylbekova EL; Musani SK; Divers J; Mychaleckyj J; Li M; Papanicolaou GJ; Millikan RC; Ambrosone CB; John EM; Bernstein L; Zheng W; Hu JJ; Ziegler RG; Nyante SJ; Bandera EV; Ingles SA; Press MF; Chanock SJ; Deming SL; Rodriguez-Gil JL; Palmer CD; Buxbaum S; Ekunwe L; Hirschhorn JN; Henderson BE; Myers S; Haiman CA; Reich D; Patterson N; Wilson JG; Price AL PLoS Genet; 2011 Apr; 7(4):e1001371. PubMed ID: 21541012 [TBL] [Abstract][Full Text] [Related]
5. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis. Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449 [TBL] [Abstract][Full Text] [Related]
6. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women. Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749 [TBL] [Abstract][Full Text] [Related]
7. Allele-specific regulation of FGFR2 expression is cell type-dependent and may increase breast cancer risk through a paracrine stimulus involving FGF10. Huijts PE; van Dongen M; de Goeij MC; van Moolenbroek AJ; Blanken F; Vreeswijk MP; de Kruijf EM; Mesker WE; van Zwet EW; Tollenaar RA; Smit VT; van Asperen CJ; Devilee P Breast Cancer Res; 2011 Jul; 13(4):R72. PubMed ID: 21767389 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of 19 susceptibility loci of breast cancer in women of African ancestry. Huo D; Zheng Y; Ogundiran TO; Adebamowo C; Nathanson KL; Domchek SM; Rebbeck TR; Simon MS; John EM; Hennis A; Nemesure B; Wu SY; Leske MC; Ambs S; Niu Q; Zhang J; Cox NJ; Olopade OI Carcinogenesis; 2012 Apr; 33(4):835-40. PubMed ID: 22357627 [TBL] [Abstract][Full Text] [Related]
9. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326 [TBL] [Abstract][Full Text] [Related]
10. Genetic susceptibility loci for subtypes of breast cancer in an African American population. Palmer JR; Ruiz-Narvaez EA; Rotimi CN; Cupples LA; Cozier YC; Adams-Campbell LL; Rosenberg L Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):127-34. PubMed ID: 23136140 [TBL] [Abstract][Full Text] [Related]
11. Fine-mapping of the 6q25 locus identifies a novel SNP associated with breast cancer risk in African-American women. Ruiz-Narváez EA; Rosenberg L; Yao S; Rotimi CN; Cupples AL; Bandera EV; Ambrosone CB; Adams-Campbell LL; Palmer JR Carcinogenesis; 2013 Feb; 34(2):287-91. PubMed ID: 23104177 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing. Robbez-Masson LJ; Bödör C; Jones JL; Hurst HC; Fitzgibbon J; Hart IR; Grose RP PLoS One; 2013; 8(11):e78839. PubMed ID: 24265722 [TBL] [Abstract][Full Text] [Related]
13. Three novel functional polymorphisms in the promoter of FGFR2 gene and breast cancer risk: a HuGE review and meta-analysis. Zhou L; Yao F; Luan H; Wang Y; Dong X; Zhou W; Wang Q Breast Cancer Res Treat; 2012 Dec; 136(3):885-97. PubMed ID: 23124475 [TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in the TOX3/LOC643714 locus and risk of breast cancer in African-American women. Ruiz-Narváez EA; Rosenberg L; Cozier YC; Cupples LA; Adams-Campbell LL; Palmer JR Cancer Epidemiol Biomarkers Prev; 2010 May; 19(5):1320-7. PubMed ID: 20406955 [TBL] [Abstract][Full Text] [Related]
15. Genetic variants on chromosome 5p12 are associated with risk of breast cancer in African American women: the Black Women's Health Study. Ruiz-Narvaez EA; Rosenberg L; Rotimi CN; Cupples LA; Boggs DA; Adeyemo A; Cozier YC; Adams-Campbell LL; Palmer JR Breast Cancer Res Treat; 2010 Sep; 123(2):525-30. PubMed ID: 20140701 [TBL] [Abstract][Full Text] [Related]
16. Replication of breast cancer GWAS susceptibility loci in the Women's Health Initiative African American SHARe Study. Hutter CM; Young AM; Ochs-Balcom HM; Carty CL; Wang T; Chen CT; Rohan TE; Kooperberg C; Peters U Cancer Epidemiol Biomarkers Prev; 2011 Sep; 20(9):1950-9. PubMed ID: 21795501 [TBL] [Abstract][Full Text] [Related]
17. Fine mapping of breast cancer genome-wide association studies loci in women of African ancestry identifies novel susceptibility markers. Zheng Y; Ogundiran TO; Falusi AG; Nathanson KL; John EM; Hennis AJ; Ambs S; Domchek SM; Rebbeck TR; Simon MS; Nemesure B; Wu SY; Leske MC; Odetunde A; Niu Q; Zhang J; Afolabi C; Gamazon ER; Cox NJ; Olopade CO; Olopade OI; Huo D Carcinogenesis; 2013 Jul; 34(7):1520-8. PubMed ID: 23475944 [TBL] [Abstract][Full Text] [Related]
18. FGFR2 genetic variants in women with breast cancer. Dix-Peek T; Dickens C; Augustine TN; Phakathi BP; Van Den Berg EJ; Joffe M; Ayeni OA; Cubasch H; Nietz S; Mathew CG; Hayat M; Neugut AI; Jacobson JS; Ruff P; Duarte RAB Mol Med Rep; 2023 Dec; 28(6):. PubMed ID: 37830168 [TBL] [Abstract][Full Text] [Related]
19. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women. Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population. Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]